This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
De Groot K, Gross WL, Herlyn K et al. (2001) Development and validation of a disease extent index in Wegener’s granulomatosis. Clin Nephrol 55:31–38
De Groot K, Gross WL, Hellmich B (2004) Therapie der primär systemischen Vaskulitiden. Internist 44: 1541–1548
Gross WL (1999) Primär systemische Vaskulitiden, Teil III: Pathogenese und Therapie. Internist 40: 1194–1215
Gross WL (Hrsg) (2000) Therapie der Immunvaskulitiden. Uni-Med-Verlag, Bremen
Jayne DR, Chapel H, Adu D et al. (2000) Intravenous immunoglobulin for ANCA-associated systemic vasculitis with persistent disease activity. Quart J Med 93: 433–439
Jayne D (2000) Evidence-based treatment of systemic vasculitis. Rheumatol 39: 585–595
Jayne D, Rasmussen N, Andrassy K et al. (2003) A randomized trial of maintainance therapy for vasculitis with antineutrophil cytoplasmic autoantibodies. N Engl J Med 349: 36–44
Reinhold-Keller E, Beuge N, Latza U et al. (2000) An interdisciplinary approach to the care of patients with Wegener’s granulomatosis: long-term outcome in 155 patients. Arthritis Rheum 43: 1021–1032
Zeuzem S, Feinman SV, Rasenack J et al. (2000) Peginterferon alfa-2a in patients with chronic hepatitis C. N Engl J Med 343: 1723–1724
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Springer-Verlag Heidelberg
About this chapter
Cite this chapter
Gause, A. (2005). Vaskulitiden. In: Schölmerich, J., et al. Medizinische Therapie 2005|2006. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-27385-9_16
Download citation
DOI: https://doi.org/10.1007/3-540-27385-9_16
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-21226-3
Online ISBN: 978-3-540-27385-1
eBook Packages: Medicine (German Language)